• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Does sST2 inhalation therapy ameliorate severe neutrophilic asthma? Analysis of neutrophil functions using intravital microscopy.

Research Project

Project/Area Number 19KK0404
Research Category

Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))

Allocation TypeMulti-year Fund
Research Field Respiratory organ internal medicine
Research InstitutionKyorin University

Principal Investigator

Masato Watanabe  杏林大学, 医学部, 非常勤講師 (00458902)

Project Period (FY) 2020 – 2023
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥15,210,000 (Direct Cost: ¥11,700,000、Indirect Cost: ¥3,510,000)
KeywordsAsthma / Neutrophil / IL-33 / sST2 / ST2 / Intravital microscopy / 喘息 / 好中球 / 生体イメージング
Outline of Research at the Start

我々は、炎症物質のIL-33が炎症細胞の好中球を肺内に引き寄せることが、難治性喘息の一因であることを発見しました。また、sST2という物質がIL-33の作用を抑えることを見つけました。そこで、sST2の吸入療法が難治性喘息の新たな治療法になるのではないかと考えました。これを証明するために、カルガリー大学で生体顕微鏡の技術を研究しているBryan G Yipp先生と共同研究を行います。我々が喘息マウスモデルを作り、Bryan先生が肺内の好中球をリアルタイムで可視化します。これにより、難治性喘息を引き起こすメカニズムを解明し、sST2吸入療法の有効性を検討します。

Outline of Final Research Achievements

In Japan, we embarked on an experiment, inhaling IL-33 and soluble ST2 in mice. To our surprise, soluble ST2 acted as a carrier protein for IL-33, significantly enhancing neutrophilic airway inflammation. We promptly reported this unexpected finding to the international journal.
In Canada, our focus was on analyzing neutrophil functions in live mice. In the Alternaria-induced neutrophilic asthma model, we observed an increase in the number and activity of neutrophils in the pulmonary microvasculature. Neutrophils were found to interact with platelets at a steady state, and this interaction was heightened in the neutrophil asthma model. However, the most surprising finding was the frequent migration of neutrophils between intra-microvascular spaces and alveoli, where they interacted with alveolar macrophages. This phenomenon was observed in both steady-state and neutrophilic asthma models, but the duration of the interaction was shorter in the neutrophilic asthma model.

Academic Significance and Societal Importance of the Research Achievements

sST2はヒトの肺内でIL-33と複合体を作り、好中球性気道炎症を増強する。IL-33-sST2複合体は炎症物質であり、治療ターゲットの候補である。
好中球性喘息モデルでは、血管内の好中球の数、移動性が増えている。好中球性喘息モデルでは血管内に好中球-血小板体複合体の数が増加した。アスピリン喘息患者では、この複合体がロイコトリエンを産生するため、この複合体が好中球性喘息の治療ターゲットの可能性がある。好中球が血管内と肺胞内の移動を繰り返し、マクロファージと相互作用することは、予想外の現象である。肺の恒常性維持のメカニズムの理解するうえで、パラダイムシフトを起こす可能性がある。

Report

(5 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • 2020 Research-status Report
  • Research Products

    (3 results)

All 2022 2021 2020

All Int'l Joint Research (1 results) Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (1 results) (of which Int'l Joint Research: 1 results)

  • [Int'l Joint Research] University of Calgary(カナダ)2020

    • Year and Date
      2020-04-20
    • Related Report
      2023 Annual Research Report
  • [Journal Article] Soluble <scp>ST2</scp> enhances <scp>IL</scp> ‐33?induced neutrophilic and pro‐type 2 inflammation in the lungs2022

    • Author(s)
      Watanabe Masato、Nakamoto Keitaro、Inui Toshiya、Sada Mitsuru、Chibana Kazuyuki、Miyaoka Chika、Yoshida Yuki、Aso Jumpei、Nunokawa Hiroki、Honda Kojiro、Nakamura Masuo、Tamura Masaki、Hirata Aya、Oda Miku、Takata Saori、Saraya Takeshi、Kurai Daisuke、Ishii Haruyuki、Takizawa Hajime
    • Journal Title

      Allergy

      Volume: 77 Issue: 10 Pages: 3137-3141

    • DOI

      10.1111/all.15401

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Soluble ST2 enhances IL-33-induced neutrophilic airway inflammation: a potential mechanism of neutrophilic asthma.2021

    • Author(s)
      Masato Watanabe
    • Organizer
      25th Congress of the APSR in Kyoto
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2020-02-06   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi